Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized, Open Label, Single Center, Single-Dose Study to Assess the Effects of Certain Nasal Medications on the Pharmacokinetics, Safety and Tolerability of PMI-150 (Intranasal Ketamine Hydrochloride) 30 mg

To see complete record on, please visit this link

Id: NCT00520104

Organisation Name: Javelin Pharmaceuticals

Overal Status: Unknown status

Start Date: August 2007

Last Update: February 29, 2008

Lead Sponsor: Javelin Pharmaceuticals

Brief Summary: This is an open label, single-center study to determine whether certain nasal medication interact with PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers and in patients with allergic rhinitis.

  • Pharmacokinetics

Total execution time in seconds: 0.27270197868347